| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Antibodies | ||
| Anti-ACE2 antibody | Abcam | Cat# ab15348 |
| Goat Anti-Rabbit IgG H&L (HRP) | Abcam | Cat# ab6721 |
| Anti-beta actin antibody [mAbcam 8226] | Abcam | Cat# ab8226 |
| Anti-Mouse IgG H&L antibody | Abcam | Cat# ab205719 |
| Bacterial and virus strains | ||
| SARS-CoV-2: pre-alpha type, D614G, B-1 strain | Hirotaka Ebina, Osaka University1 | NCBI: LC603286 |
| SARS-CoV-2: gamma variant, TY7-501 strain | National Institute of Infectious Diseases | GISAID ID : EPI_ISL_833366 |
| SARS-CoV-2: delta variant, BK325 strain | Research Foundation for Microbial Diseases of Osaka University | N/A |
| SARS-CoV-2: omicron variant, TY38-873 strain | National Institute of Infectious Diseases | GISAID ID : EPI_ISL_7418017 |
| JM109 competent cells | SMOBIO | Cat# CC0202 |
| Chemicals, peptides, and recombinant proteins | ||
| 5-Fluorouracil | FUJIFILM Wako | Cat# 068-01401 |
| KOD One PCR Master Mix -Blue- | TOYOBO | Cat# KMM-201 |
| PrimeSTAR GXL DNA polymerase | TaKaRa Bio | Cat# R050A |
| Lipofectamin LTX Reagent with PLUS™ Reagent | Invitrogen | Cat# 15338100 |
| SeaPlaque Agarose | LONZA | Cat# 50100 |
| TriReagent | Molecular Research Center | Cat# TR118 |
| Dulbecco’s modified Eagle’s Medium (DMEM) | Sigma-Aldrich | Cat# D6429 |
| Minimum Essential Medium Eagle (MEM) | Sigma-Aldrich | Cat# M4655 |
| Dulbecco's phosphate-buffered saline (D-PBS) | Nacalai Tesque | Cat# 14249 |
| Fetal bovine serum (FBS) | Sigma-Aldrich | Cat# F7524 |
| Penicillin (100 U/mL), and streptomycin (0.1 mg/mL) (PS) | Gibco | Cat# 1154887 |
| Puromycin | Gibco | Cat# A1113803 |
| G418 Sulfate, Geneticin | Gibco | Cat# 10131027 |
| Opti-MEM | Gibco | Cat# 31985062 |
| XbaI | NEB | Cat# R0145 |
| NotI | NEB | Cat# R0189 |
| rCutSmart Buffer | NEB | Cat# B6004 |
| Polyethylenimine "Max" (PEI “Max”) | Polysciences, Inc. | Cat# 24765 |
| Canget signal solution I | TOYOBO | Cat# NKB-201 |
| Canget signal solution II | TOYOBO | Cat# NKB-301 |
| ECL Prime Western Blotting Detection Reagents | Cytiva | Cat# RPN2232 |
| RIPA buffer | Thermo Scientific | Cat# 89900 |
| proteinase inhibitor cocktail | Thermo Scientific | Cat# 78430 |
| Plus Protein Dual Color Standards | BIO-RAD | Cat#1610374 |
| EzApply | ATTO | Cat# AE-1430 |
| EzRun buffer | ATTO | Cat#AE-1410 |
| Trans-Blot Turbo Mini 0.2 μm PVDF Transfer Packs | Bio-Rad Laboratories, Inc. | Cat# 1704156 |
| 10×TBS | Bio-Rad Laboratories, Inc. | Cat# 1706435 |
| Tween-20 (polyoxyethylene sorbitan monolaurate) | Nacalai Tesque | Cat# 35624-15 |
| PVDF blocking reagent | TOYOBO | Cat# NYPBR01 |
| e-PAGEL HR gel | ATTO | Cat#EHR-R1020L |
| Critical commercial assays | ||
| QIAamp viral RNA mini kit | QIAGEN | Cat# 52904 |
| SuperScript™ III First-Strand Synthesis System for RT-PCR | Invitrogen | Cat# 18080051 |
| DNA Ligation Kit Ver.2.1 | TaKaRa Bio | Cat# 6022 |
| GenNext RamDA-seq Single Cell Kit | TOYOBO | Cat# RMD-101 |
| Nextera XT DNA Library Prep Kit | Illumina | Cat# FC-131-1096 |
| Nextera XT Index Kit v2 | Illumina | Cat# FC-131 |
| Deposited data | ||
| Viral genome sequence of B-1 strain | Hirotaka Ebina, Osaka University1 | NCBI: LC603286 |
| Viral genome sequence of A50-18 strain | Hirotaka Ebina, Osaka University1 | NCBI: LC603287 |
| Viral genome sequence of H50-11 strain | Hirotaka Ebina, Osaka University1 | NCBI: LC603288 |
| Viral genome sequence of L50-33 strain | Hirotaka Ebina, Osaka University1 | NCBI: LC603289 |
| Viral genome sequence of L50-40 strain | Hirotaka Ebina, Osaka University1 | NCBI: LC603290 |
| Experimental models: Cell lines | ||
| Green monkey: Vero cells | ATCC | Cat# CCL-81; RRID: CVCL_0059 |
| Green monkey: Vero cells with constitutive expression of TMPRSS II, VeroE6-TMPRSS II cells | Japanese Collection of Research Bioresources Cell Bank | Cat# JCRB1819; RRID: CVCL_YQ49 |
| Syrian hamster: BHK-21(C-13) cells | Japanese Collection of Research Bioresources Cell Bank | Cat# JCRB9020; RRID: CVCL_1915 |
| Syrian hamster: BHK-21(C-13) cells with constitutive expression of hACE2, BHK-hACE2 cells | This paper | N/A |
| Human 293T cells LX-293 | ATCC | CRL-3216 |
| Oligonucleotides | ||
| hACE2-cloning-Fw (AAATCTAGACGA TGTCAAGCTCTTCCTGGCTCCT) |
Hirotaka Ebina, Osaka University1 | N/A |
| hACE2-cloning-Rv (TTTGCGGCC GCTAAAAGGAGGTCTGAACATC ATCAGTGTTTTG) |
Hirotaka Ebina, Osaka University1 | N/A |
| CoV-2-F1-Fw (CTATATAAGCAG AGCTCGTTTAGTGAACCGT attaaaggtttataccttcccaggtaac) |
Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-F1-Rv (cagattcaacttgcat ggcattgttagtagccttatttaaggctcctgc) |
Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-F2-Fw (gcaggagccttaaataa ggctactaacaatgccatgcaagttgaatctg) |
Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-F2-Rv (ggtaggattttccacta cttcttcagagactggttttagatcttcgcaggc) |
Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-F3-Fw (gcctgcgaagatctaaaa ccagtctctgaagaagtagtggaaaatcctacc) |
Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-F3-Rv (ggtgcacagcgcagcttct tcaaaagtactaaagg) |
Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-F4-Fw (caccactaattcaaccta ttggtgctttggacatatcagcatctatagta gctggtgg) |
Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-F4-Rv (gtttaaaaacgattg tgcatcagctgactg |
Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-F5-Fw (cacagtctgtaccgtctgcgg tatgtggaaaggttatggctgtagttgtgatc) |
Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-F5-Rv (gcggtgtgtacatagcct cataaaactcaggttcccaataccttgaagtg) |
Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-F6-Fw (cacttcaaggtattggga acctgagttttatgaggctatgtacacaccgc) |
Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-F6-Rv (catacaaactgccaccatca caaccaggcaagttaaggttagatagcactctag) |
Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-F7-Fw (ctagagtgctatctaacctt aacttgcctggttgtgatggtggcagtttgtatg) |
Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-F7-Rv (ctagagactagtggcaataa aacaagaaaaacaaacattgttcgtttagttgttaac) |
Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-F8-Fw (gttaacaactaaacgaacaa tgtttgtttttcttgttttattgccactagtctctag) |
Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-F8-Rv (gcagcaggatccacaagaa caacagcccttgagacaactacagcaactgg) |
Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-F9-Fw (ccagttgctgtagttgtctca agggctgttgttcttgtggatcctgctgc) |
Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-F9-Rv (caatctccattggttgctcttcatc) | Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-F10-Fw (gatgaagagcaaccaatggagattg) | Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-F10-Rv (GGAGATGCCATG CCGACCCtttttttttttttttttttttttttgtca ttctcctaag) |
Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-Linker-Fw (cttaggagaatgacaaa aaaaaaaaa aaaaaaaaaaaaaGGGTCGG CATGGCATCTCC) |
Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-Linker-Rv (gttacctgggaaggta taaacctttaatACGGTTCACTAAACGA GCTCTGCTTATATAG) |
Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-TS-F6-Rv (catacaaactgccacta tcacaaccaggcaagttaaggttagatagcactctag) |
Hirotaka Ebina, Osaka University1 | N/A |
| CoV-2-TS-F7-Fw (ctagagtgctatctaaccttaa cttgcctggttgtgatagtggcagtttgtatg) |
Hirotaka Ebina, Osaka University1 | N/A |
| CoV-2-4052T-Fw (tatattgacattaatggca attttcatccagattctgcca) |
Hirotaka Ebina, Osaka University1 | N/A |
| CoV-2-4052T-Rv (ttgccattaatgtcaatataa agtaacaagttttctgtga) |
Hirotaka Ebina, Osaka University1 | N/A |
| CoV-2-18782T-Fw (tgattgatgttcaacaatgg gtttttacaggtaacctaca) |
Hirotaka Ebina, Osaka University1 | N/A |
| CoV-2-18782T-Rv (ccattgttgaacatcaat cataaacggattatagacgtaa) |
Hirotaka Ebina, Osaka University1 | N/A |
| CoV-2-19285A-Fw (aaccttaacttgcctggttg tgatagtggcagtttgtatg) |
Hirotaka Ebina, Osaka University1 | N/A |
| CoV-2-19285A-Rv (caaccaggcaagttaaggt tagatagcactctagtgtcaa) |
Hirotaka Ebina, Osaka University1 | N/A |
| CoV-2-19550T-Fw (tctcgatgcttataacatga tgatctcagttggctttagc) |
Hirotaka Ebina, Osaka University1 | N/A |
| CoV-2-19550T-Rv (tcatgttataagcatcgagata caatctgtactcattagc) |
Hirotaka Ebina, Osaka University1 | N/A |
| CoV-2-20857A-Fw (ctgtaccctataatatga gaattatacattttggtgctggttct) |
Hirotaka Ebina, Osaka University1 | N/A |
| CoV-2-20857A-Rv (tctcatattatagggtacagc taatgttaatgtgtttaaa) |
Hirotaka Ebina, Osaka University1 | N/A |
| CoV-2-G2-Fw (cggcagtgaggacaatcagacaactac) | Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-G2-Rv (ggcttagcataattagctatagtatcccaagggac) | Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-G6-Fw (tgtagatgatatcgtaaaaacagatggtacac) | Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-G6-Rv (aacgtgttatacacgtagcagactttagtggtac) | Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-G7-Fw (aaaggttcaacacatggttgttaaagctgc) | Yoshiharu Matsuura, Osaka University5 | N/A |
| CoV-2-G7-Rv (cgtacactttgtttctgagagagggtc) | Yoshiharu Matsuura, Osaka University5 | N/A |
| covid-dp-4655-4683r (ggcactttgagagatctcatataccgagc) | Yoshiharu Matsuura, Osaka University5 | N/A |
| covid-dp-18160-18186f (gttgacatacctggcatacctaaggac) | Yoshiharu Matsuura, Osaka University5 | N/A |
| covid-dp-19712-19738r (caacaccatcaacttttgtgtaaacag) | Yoshiharu Matsuura, Osaka University5 | N/A |
| covid-dp-20470-20496f (gcgcaaacaggttcatctaagtgtgtg) | Yoshiharu Matsuura, Osaka University5 | N/A |
| Recombinant DNA | ||
| PiggyBac cDNA Cloning and Expression Vector | System Biosciences | PB514B-2 |
| transposase expression vector | System Biosciences | PB200A-1 |
| Software and algorithms | ||
| CLC Genomics Workbench 21 | QIAGEN | N/A |
| Other | ||
| ImageQuant LAS-500 system | Cytiva | N/A |
| MiSeq platform | Illumina | N/A |